Several serological parameters presented a significant association with the current classification of samples as belonging to patients with definite PBC (Table 3), including high titer IIF-AMA, triple isotype IIF-AMA, high titer and high avidity anti-PDC-E2 antibodies, and three or more cellular domains recognized by autoantibodies. The gene discussed is DLAT; the disease is primary biliary cholangitis.